Literature DB >> 9990685

Skeletal metastases from breast cancer: imaging with nuclear medicine.

G J Cook1, I Fogelman.   

Abstract

Breast cancer is a disease that commonly metastasizes to bone, increasing morbidity, mortality, and health service costs. The 99m technetium (99mTc) diphosphonate bone scan historically has played a significant part in the evaluation of skeletal disease and continues to be one of the most clinically utilized investigations in the staging and follow up of breast cancer patients. More tumor-specific radiopharmaceuticals are now being evaluated and, in particular, 18-fluoro-2-deoxyglucose positron emission tomography (18FDG PET) may have a greater role in this disease in the future.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9990685     DOI： 10.1016/s0001-2998(99)80031-2

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN： 0001-2998            Impact factor:   4.446


  9 in total

1.  Bone scintigraphy: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Morteímans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

2.  Role of bone scintigraphy and tumor marker-Ca 15-3 in detection of bone metastases in patients with breast cancer.

Authors:  Amela Begić; Elma Kucukalić-Selimović; Nermina Obralić; Osman Durić; Nadir Lacević; Sadzida Begović; Mirela Dzubur-Aganović
Journal:  Bosn J Basic Med Sci       Date:  2005-02       Impact factor: 3.363

Review 3.  Advantages and limitations of FDG PET in the follow-up of breast cancer.

Authors:  Peter Lind; Isabel Igerc; Thomas Beyer; Peter Reinprecht; Klaus Hausegger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-15       Impact factor: 9.236

4.  Correlation between bone scintigraphy and tumor markers in patients with breast carcinoma.

Authors:  Amela Begić; Elma Kucukalić-Selimović; Nermina Obralić; Osman Durić; Nadir Lacević; A Skopljak
Journal:  Bosn J Basic Med Sci       Date:  2006-02       Impact factor: 3.363

Review 5.  Bone as an effect compartment : models for uptake and release of drugs.

Authors:  David Stepensky; Lilach Kleinberg; Amnon Hoffman
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 6.  Current imaging techniques in rheumatology: MRI, scintigraphy and PET.

Authors:  Iwona Sudoł-Szopińska; Jarosław B Cwikła
Journal:  Pol J Radiol       Date:  2013-07

Review 7.  Multimodal Imaging-Based Potential Visualization of the Tumor Microenvironment in Bone Metastasis.

Authors:  Jang Bae Moon; Su Woong Yoo; Changho Lee; Dong-Yeon Kim; Ayoung Pyo; Seong Young Kwon
Journal:  Cells       Date:  2021-10-25       Impact factor: 6.600

Review 8.  The role of general nuclear medicine in breast cancer.

Authors:  Lacey R Greene; Deborah Wilkinson
Journal:  J Med Radiat Sci       Date:  2015-02-12

9.  The EANM practice guidelines for bone scintigraphy.

Authors:  T Van den Wyngaert; K Strobel; W U Kampen; T Kuwert; W van der Bruggen; H K Mohan; G Gnanasegaran; R Delgado-Bolton; W A Weber; M Beheshti; W Langsteger; F Giammarile; F M Mottaghy; F Paycha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-04       Impact factor: 9.236
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.